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Abstract 
Background: Internal jugular cannula position is traditionally confirmed via plain film at 
the conclusion of the peripheral ECMO cannulation procedure. However, it may be 
difficult to estimate the location of the right atrium on plain films. A misplaced cannula 
can result in need for repositioning and increased morbidity. Echocardiography (ECHO) 
may be used during cannulation as a more accurate means of guiding cannula position. 
The aim of this study is to study the effect of a protocol encouraging the routine use of 
ECHO at the time of cannulation.  
Objective: To assess whether the use of echocardiographic guidance during neonatal and 
pediatric jugular cannulation for ECMO reduces the need for cannula repositioning or 
decreases morbidity.    
Methods and Materials:  We performed a retrospective review of patients at a single 
institution who received ECMO support using jugular venous cannulation from January 
2013 through October 2016. We compared those who underwent ECHO (ECHO+) at the 
time of cannulation with those who did not (ECHO-). Patient demographics and surgical 
history, ECMO cannulation details, ECMO events, need for cannula repositioning, cannula 
related morbidity, and patient outcomes were noted. The results were analyzed with 
descriptive and non-parametric statistics where applicable. 
Results: 89 patients met inclusion criteria: 26 ECHO+ (29%), 63 ECHO- (71%). Most of 
ECHO+ patients underwent dual-lumen VV cannulation (n=17, 65%), while 32% of 
ECHO- patients had VV support (p<0.003). Seven (27%) ECHO+ patients and 18 (28%) 
ECHO- patients had a history of cardiac surgery prior to ECMO (p=0.88). All patients had 
CXR to verify cannula position, and fluoroscopy was used in 4 ECHO+ patients but no 
ECHO- patients. There was a major mechanical complication in each group: atrial 
perforation from a guidewire during cannulation in ECHO+ and late atrial perforation from 
a loose cannula in ECHO-. Subsequent to cannulation, there were 0.58 ECHO studies per 
patient to verify cannula position in the ECHO+ group compared to 0.22 ECHO per patient 
in the ECHO- group (p=0.02).  Two (8%) ECHO+ patients required a cannula repositioning 
procedure for misplacement during the ECMO run, while 6 (10%) ECHO- patients required 
repositioning procedures (p=0.78). In the VV ECMO subgroup, ECHO+ patients required 
no repositioning, while 4 (20%) of ECHO- VV patients required repositioning (p=0.1). 
Patients who had ECHO to verify cannula placement during the ECMO run were more 
likely to have a repositioning procedure (p<0.001). Repositioning procedures resulted in 
no additional complications.  Survival to discharge was similar in both groups: 54% 
ECHO+ and 62% ECHO- (p=0.51).   
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Conclusion: Implementation of a protocol to perform ECHO during jugular cannulations 
for neonatal and pediatric peripheral ECMO did not result in significantly less 
repositioning procedures, complications, or ECHO studies performed per patient.  ECHO 
may still be a useful adjunct for surgeons during difficult cannulations and for precise 
placement of a dual-lumen VV cannula, but this study does not support routine use.  
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Introduction 
 
Extracorporeal membrane oxygenation (ECMO) enables cardiovascular and pulmonary 
recovery by providing prolonged cardiac and/or pulmonary bypass in the intensive care 
setting to severely ill patients with recoverable disease. ECMO cannulation involves the 
precise placement of a large catheter (cannula) within the central venous system for blood 
drainage from the patient to the ECMO circuit. More over, the majority of neonatal and 
pediatric ECMO support involves drainage of blood from the right atrium through the 
placement of a cannula within the right jugular vein with subsequent radiographic imaging 
to confirm cannula position.  
 
Nevertheless, it is often difficult to estimate the location of the right atrium on plain films, 
and a misplaced cannula can result in ineffective ECMO support, significant morbidity to 
the patient, and excessive resource utilization to reposition the cannula. Blind cannulation 
can result in cardiac or vascular injury, and a cervical repositioning procedure while 
anticoagulated on ECMO can lead to morbidity from bleeding.1 As a result, recent literature 
has encouraged the use of echocardiography (ECHO) as a more accurate means of 
assessing cannula position by demonstrating that ECHO performed at the time of cannula 
placement reduces the need for cannula repositioning and may reduce morbidity associated 
with misplaced cannulae.2-4 Therefore, we set out to decipher the clinical and institutional 
effect after initiating a protocol encouraging the routine use of ECHO at the time of right 
internal jugular cannula placement in January 2015. Our primary aim was to determine if 
ECHO use decreased the need for cannula repositioning during the ECMO run. Our 
secondary aims were to evaluate for a change in cannula-related morbidity and resource 
utilization related to the ECHO protocol.   
 
 
Methods and Materials  
 
Following institutional review board approval (Indiana University IRB protocol 
#1610913759), a retrospective review of patients at Riley Hospital for Children who 
received ECMO support using jugular venous cannulation from January 2013 through 
October 2016 was performed. We compared those who underwent ECHO (ECHO+) at the 
time of cannulation with those who did not (ECHO-).  
 
Cannulation Technique 
 
Cannulations were performed by a group of eight Pediatric General Surgeons in an 
Extracorporeal Life Support Organization ECMO center of excellence. All veno-arterial 
(VA) cannulations were through an open cervical cutdown technique. Ideal venous cannula 
tip placement was defined as mid right atrium with adequate ECMO flow to support the 
patient. The majority of veno-venous (VV) cannulations were through an open cervical 
cutdown technique, but there were some percutaneous cannulations. All VV cannulations 
were with the OriGen dual lumen cannula (OriGen Biomedical, Austin, Texas, USA). Ideal 
venous cannula tip placement was defined as low right atrium with adequate ECMO flow 
to support the patient.  
 
ECHO Technique 
 
Transthoracic echocardiography was performed under the sterile drapes at the time of 
ECMO cannulation with the patient in the supine position. The preferred imaging approach 
was subcostal with demonstration of the superior vena cava, right atrium, tricuspid valve, 
and right ventricle, typically utilizing a subcostal four-chamber view or bi-caval view. This 
allows for best visualization of the venous cannula to ensure it is past the right atrial-
superior vena cava junction, ideally in the low right atrium directed predominately toward 
the tricuspid valve (Fig 1A).  
 
Furthermore, this view allows physicians to quickly assess the cannula to determine if it is 
undesirably deep (i.e. traverses the tricuspid valve or is into the right ventricular chamber) 
or if the cannula crosses a patent foramen ovale or atrial septal defect into the left atrium. 
In the event subcostal imaging quality is suboptimal or unobtainable, other views are 
utilized including apical four-chamber and parasternal long and short axis views. The 
addition of color Doppler was added to imaging to ensure proper venous inflow and 
outflow in the setting of veno-venous ECMO (Fig 1B). Cannula position was adjusted 
under ECHO guidance until the tip location was ideal and ECMO flow was optimal. 
Figure 1 A: Echocardiography utilizing subcostal imaging window with demonstration of 
the superior vena cava (SVC), left atrium (LA), right atrium (RA), tricuspid valve (TV), 
right ventricle (RV) and venous cannula. Note tip of cannula in mid-lower right atrium.  
 
 
 
Figure 1B: Echocardiography in same imaging plane now with color Doppler showing 
venous cannula outflow (Red color labeled “Cannula Flow”) directed toward the 
tricuspid valve as desired. 
 
 
Variables and Statistics 
 
We examined patient demographics and surgical history, ECMO cannulation details, 
ECMO events, need for cannula repositioning, cannula related morbidity, and overall 
patient outcomes. ECHO performed at time of cannulation is reported separately from 
subsequent ECHO studies performed during ECMO support to verify cannula placement. 
Any cannula repositioning procedure was a separate event from the original cannulation 
procedure and was at least 24 hours after initiation of ECMO.  
 
For categorical variables, Fisher's exact or Chi-square tests were used to assess for 
significance, and significance was defined as p<0.05. All statistical analysis was performed 
on SAS version 9.4 (Cary, NC). 
 
 
Results 
 
Demographics and Survival 
 
There were 26 patients in the ECHO+ group and 63 in the ECHO- group. Table 1 shows 
the demographic breakdown of neonatal vs. pediatric patients in each group and ECMO 
diagnostic categories. The ECHO+ group had a significantly higher proportion of pediatric 
patients as opposed to a higher proportion of neonates in ECHO-. There was no significant 
difference in diagnoses or survival to discharge between the groups. All patients had a chest 
x-ray performed at the end of cannulation to verify cannula position. Fluoroscopy during 
cannulation was used in 4 ECHO+ patients, and no ECHO- patients underwent 
fluoroscopy.  
 
 ECHO (+) ECHO (-) P-Value 
N, Sample Size (%) 26 (29) 63 (70) --- 
 
Neonatal (< 1 month) 4 (15) 35 (56)  
<0.001 Pediatric (> 1 month) 22 (85) 28 (44) 
 
Cardiac  8 (31) 23 (37)  
 
0.11 
Respiratory 18 (69) 32 (51) 
CDH  0 8 (12) 
 
Survival to Discharge 14 (54) 39 (62) 0.51 
Table 1. Demographics and Survival 
 
Modes of Cannulation 
Sixty-five percent of patients in the ECHO+ group were placed on VV ECMO support 
(17/26), while 35% of ECHO+ patients underwent VA ECMO support (9/26, Figure 2). 
Thirty-two percent of patients in the ECHO- group underwent VV ECMO (20/63), while 
68% of ECHO- patients were supported with VA ECMO (43/63).  This was statistically 
significant, with a p-value of 0.003.  
 
 
 
Cannula Repositioning  
Eight patients required a jugular cannula repositioning procedure during their ECMO run 
after initial cannulation, and no patient had more than one repositioning procedure. There 
was no significant difference in repositioning when comparing the two groups: 2/26 (8%) 
ECHO+ vs. 6/63 (10%) ECHO-, p=0.78 (Figure 3). Patients who had an ECHO performed 
during their ECMO run to verify cannula position had greater likelihood of undergoing a 
cannula repositioning procedure: 7/20 (35%) ECHO during ECMO vs. 1/69 (1.5%), 
p<0.001 (Figure 3). There were 0.58 ECHO studies per patient performed to verify cannula 
position in the ECHO+ group, compared to 0.22 ECHO studies per patient in the ECHO- 
group (p=0.02).  
 
In the VV ECMO subgroup, 0/17 ECHO+ patients required cannula repositioning, while 
4/20 (25%) ECHO- patients required cannula repositioning (p=0.1, Table 2). In the VA 
ECMO subgroup, 2/9 (22%) ECMO+ patients required cannula repositioning, while 2/43 
(4.6%) ECHO- patients required repositioning (p=0.07).  
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Complications 
Each group had one major complication. In the ECHO+ group, there was an atrial guide 
wire perforation during a percutaneous VV cannulation. Fluoroscopy was not used in that 
procedure. In the ECHO- group, there was an atrial cannula perforation during the ECMO 
run after initial cannulation. This was also in the setting of a VV cannula. There was no 
significant difference in any minor complication when comparing ECHO+ and ECHO- 
groups. Additionally, repositioning procedures resulted in no additional complications.  
Cannula site bleeding occurred in 37% (3/8) of patients requiring cannula repositioning, 
and it occurred in 27% (22/81) of patients who did not require repositioning (p=0.53). 
 
 
 
Discussion  
 
Despite ECMO’s use for over four decades, there are no evidence-based guidelines for the 
proper method of evaluating ECMO cannula position during cannulation, with most 
cannulators traditionally obtaining chest X-rays after cannula placement. Nevertheless, in 
a 1994 review of complications reported to the extracorporeal life support organization 
registry by Zwischenberger et al., cannula malposition occurred in 9% of all ECMO 
cannulations.5 Abnormal sites include against the interatrial septum, through a patent 
foramen ovale and into the left atrium, in the coronary sinus, and across the tricuspid valve 
or subvalvular apparatus, with venous cannulae being more likely to be incorrectly 
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Fig 3. Patients Requiring Cannula Repositioning
Yes
No
p=0.78 p<0.001
Mode of Cannulation ECHO (+) ECHO (-) P-Value 
VV 0/17 4/20 0.10 
VA 2/9 2/43 0.13 
Table 2. Cannula Repositioning Separated by Mode of Cannulation 
positioned than arterial cannulae. In addition, malpositioning may result in cardiac or 
vascular injury in addition to inadequate flows. A malpositioned cannula requires 
manipulation or reoperation to achieve the appropriate location for adequate flow and 
ECMO support. In turn, this places patients at risks for infections, bleeding, or 
cardiovascular injury, in addition to the added healthcare costs of re-intervention. Only 
more recently has data been presented in the literature to recommend ECHO or fluoroscopy 
during cannulation to avoid some of these issues.2-4,6   
 
This study set out to assess whether the use of ECHO guidance during neonatal and 
pediatric jugular cannulation for ECMO reduced the need for cannula repositioning or 
decreased morbidity. In designing the protocol reported in this study, our goal was to 
perform ECHO on all ECMO patients during cannulation after initiation of the protocol.  
However, the results summarized in Table 1 and Figure 2 show a clear bias in our patient 
groups. The ECHO+ group included a higher percentage of pediatric, respiratory, and VV 
patients, while the ECHO- group included more neonatal, cardiac/CDH, and VA patients.  
This result was interesting but not wholly unexpected. The OriGen dual-lumen cannula 
requires precise cannula tip placement for optimal flow and to prevent cardiovascular 
injury, whereas single lumen jugular venous cannula tip location in VA ECMO is generally 
less rigorous to attain proper support. In the end, individual surgeons chose whether or not 
to have an ECHO at cannulation.  Perhaps they made their decisions based on comfort with 
the cannulation procedure or based on this element of precision.  Further, most patients go 
on VV ECMO for respiratory failure, and it has been shown that patients undergoing VV 
cannulation have a higher likelihood of being older, as seen by Zahraa, et al.7 
 
Our finding that there was no difference in cannula repositioning procedures required 
between the two groups conflicted with our initial hypothesis that ECHO would result in 
less repositioning procedures, as suggested by previous studies2-4.  Cannula repositioning 
rates of 8 and 10 percent, while low in both groups, may have been affected by the small 
patient population in our study as compared to previously published work. Ours is the first 
study to compare repositioning procedures between the VV and VA populations. Of note, 
there were no cannula repositioning procedures required in our ECHO+ VV patients, as 
compared to 20% of the ECHO- VV group.  This trended towards significance and shows 
an advantage of the use of ECHO during VV cannulation.  To the contrary, the trend 
towards more repositioning in the ECHO+ VA patients shows no benefit of ECHO in that 
population.  
 
We were also interested in whether the ECHO protocol would result in decreased resource 
utilization at our institution. As noted above, there were similar operating room resources 
used in repositioning procedures. Surprisingly, we found that the ECHO+ group underwent 
more ECHO studies per patient than the ECHO- group during the ECMO runs after initial 
cannulation.  This could be due to the higher proportion of VV patients in the ECHO+ 
group requiring more ECHO studies for precise localization of the cannula tip.  
Alternatively, it could be due to more ECHO studies being ordered by the ICU providers 
in the later time period of the study, correlating with more ECHO+ patients. By 
encouraging the use of ECHO at cannulation, did more physicians begin to not only use it 
at cannulation, but also more freely during the respective ECMO runs to verify placement? 
With the retrospective nature of this study and sheer number of physicians caring for these 
patients, these decision points are difficult to decipher.  A future study might prospectively 
follow a controlled group of patients with a rigid care protocol or small number of 
physicians making these decisions.    
 
There were no significant differences in major or minor complications in both groups. 
However, it is important to note that ECHO did not prevent atrial perforation from a 
guidewire during a percutaneous VV cannulation in the absence of fluoroscopy, and even 
one atrial perforation is one too many. Thus, other adjuncts such as fluoroscopy should be 
considered in percutaneous cannulation.6 Unfortunately, these complications are not 
uncommon. In a retrospective institutional analysis, Rupprecht et al. have shown that one 
of the major complications of percutaneous ECMO is cannulation itself, with an 8.8% risk 
of vessel puncture and a 5.7% risk of significant blood loss.8 Additionally, bleeding 
complications on ECMO are common, and a high incidence of cannula site bleeding can 
be attributed to systemic anticoagulation, circuit-induced coagulopathy, and systemic 
disease processes.9 We found no difference in cannula site cervical bleeding between the 
two groups, and importantly, we found no effect of cannula repositioning on bleeding 
complications. 
 
 
Conclusion 
 
There are currently no guidelines that have been developed from large data sets with respect 
to the optimal imaging modality to help guide ECMO cannulation. This study shows that 
the implementation of an institutional protocol to encourage ECHO use during jugular 
cannulation for neonatal and pediatric ECMO did not result in significantly less 
repositioning procedures, complications, or resource utilization. However, ECHO may still 
be a useful adjunct for surgeons during difficult cannulations and for precise placement of 
dual-lumen VV cannulae. Further studies should prospectively follow patients in a 
protocolized care model to better estimate the effect of protocol change to help form better 
guidelines for clinicians when placing patients on ECMO support.   
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